An FDA panel spread misinformation about SSRI use in pregnancy, alarming doctors

Nearly one in five pregnant women and new moms in this country suffers from anxiety and depression. And 6-8% of pregnant women are prescribed a group of antidepressants called Selective Serotonin Reuptake Inhibitors (SSRIs).

But a recent expert panel organized by the U.S. Food and Drug Administration cast doubt on the safety of SSRIs — even though these drugs are largely considered safe by healthcare providers.